Clinical and immunological effect of subcutaneous immunotherapy in allergic asthma
Conclusion SCIT is a safe treatment strategy that significantly reduce exacerbation and medication requirement in allergic asthma without mixed allergy also improve immunological response.
Source: Egyptian Journal of Chest Diseases and Tuberculosis - Category: Respiratory Medicine Source Type: research
More News: Allergy | Allergy & Immunology | Asthma | Hay Fever | Immunotherapy | Pulmonary Function Testing | Respiratory Medicine | Skin | Study | Tuberculosis